Treating Prostate Cancer in Older Patients
This video reviews the management approach for prostate cancer in older patients, including when screening is appropriate and how geriatric assessments can guide treatment decisions.
In this video, William Dale, MD, PhD, of the City of Hope Cancer Center in Duarte, California, discusses the management approach for prostate cancer in older patients, including when screening is appropriate and how geriatric assessments can guide treatment decisions.
Dale spoke on this topic during an education session, “Disparities in Screening and Treatment of Prostate Cancer for the Older Patient,” at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting last month in Chicago.
FDA Approves Encorafenib/Cetuximab Plus mFOLFOX6 for Advanced BRAF V600E+ CRC
December 20th 2024The FDA has granted accelerated approval to encorafenib in combination with cetuximab and mFOLFOX6 for patients with metastatic colorectal cancer with a BRAF V600E mutation, as detected by an FDA-approved test.
